Design of liposomes as drug delivery system for therapeutic applications
- PMID: 33812967
- DOI: 10.1016/j.ijpharm.2021.120571
Design of liposomes as drug delivery system for therapeutic applications
Abstract
Liposomes are spherical vesicles consisting of one or more concentric phospholipid bilayers enclosing an aqueous core. Being both nontoxic and biodegradable, liposomes represent a powerful delivery system for several drugs. They have improved the therapeutic efficacy of drugs through stabilizing compounds, overcoming obstacles to cellular and tissue uptake and increasing drug biodistribution to target sites in vivo, while minimizing systemic toxicity. This review offers an overview of liposomes, thought the exploration of their key fundamentals. Initially, the main design aspects to obtain a successful liposomal formulation were addressed, following the techniques for liposome production and drug loading. Before application, liposomes required an extensive characterization to assurance in vitro and in vivo performance. Thus, several properties to characterize liposomes were explored, such as size, polydispersity index, zeta potential, shape, lamellarity, phase behavior, encapsulation efficiency, and in vitro drug release. Topics related with liposomal functionalization and effective targeting strategies were also addressed, as well as stability and some limitations of liposomes. Finally, this review intends to explore the current market liposomes used as a drug delivery system in different therapeutic applications.
Keywords: Drug delivery; Liposome characterization; Liposome production; Liposomes; Market liposomes.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes.Int J Pharm. 2021 Jan 5;592:120051. doi: 10.1016/j.ijpharm.2020.120051. Epub 2020 Nov 5. Int J Pharm. 2021. PMID: 33161039
-
Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.Int J Nanomedicine. 2015 Oct 1;10 Suppl 1(Suppl 1):149-57. doi: 10.2147/IJN.S79994. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26491316 Free PMC article.
-
Liposome-based delivery system for vaccine candidates: constructing an effective formulation.Nanomedicine (Lond). 2012 Dec;7(12):1877-93. doi: 10.2217/nnm.12.157. Nanomedicine (Lond). 2012. PMID: 23249332 Review.
-
Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.J Control Release. 2016 Jun 28;232:228-37. doi: 10.1016/j.jconrel.2016.04.031. Epub 2016 Apr 23. J Control Release. 2016. PMID: 27112112
-
Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes.Artif Cells Nanomed Biotechnol. 2023 Dec;51(1):428-440. doi: 10.1080/21691401.2023.2247036. Artif Cells Nanomed Biotechnol. 2023. PMID: 37594208 Review.
Cited by
-
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond.Theranostics. 2024 Oct 14;14(17):6726-6767. doi: 10.7150/thno.100667. eCollection 2024. Theranostics. 2024. PMID: 39479446 Free PMC article. Review.
-
Effect of Cyclodextrins Formulated in Liposomes and Gold and Selenium Nanoparticles on siRNA Stability in Cell Culture Medium.Pharmaceuticals (Basel). 2024 Oct 8;17(10):1344. doi: 10.3390/ph17101344. Pharmaceuticals (Basel). 2024. PMID: 39458985 Free PMC article.
-
Evaluation of anti-Toxoplasma effects of solid lipid nanoparticles carrying Cinnamon zeylanicum and Moringa oleifera oil extracts.BMC Complement Med Ther. 2024 Oct 24;24(1):375. doi: 10.1186/s12906-024-04677-x. BMC Complement Med Ther. 2024. PMID: 39449016 Free PMC article.
-
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy.RSC Med Chem. 2024 Oct 3. doi: 10.1039/d4md00517a. Online ahead of print. RSC Med Chem. 2024. PMID: 39430954 Free PMC article.
-
Bio-Inspired Nanodelivery Platform: Platelet Membrane-Cloaked Genistein Nanosystem for Targeted Lung Cancer Therapy.Int J Nanomedicine. 2024 Oct 16;19:10455-10478. doi: 10.2147/IJN.S479438. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39430311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources